UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 454

Sortiert nach

Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention

Cancer prevention research (Philadelphia, Pa.), 2011-11, Vol.4 (11), p.1728-1735

2011

Volltextzugriff (PDF)

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer

Advanced science, 2022-09, Vol.9 (26), p.e2105885-n/a

2022

Volltextzugriff (PDF)

Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention

Frontiers in immunology, 2021-08, Vol.12, p.729809-729809

2021

Volltextzugriff (PDF)

Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity

Biochemical pharmacology, 2010-12, Vol.80 (12), p.2042-2049

2010

Volltextzugriff (PDF)

Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods

PloS one, 2012-05, Vol.7 (5), p.e38261

2012

Volltextzugriff (PDF)

Taxifolin suppresses UV-induced skin carcinogenesis by targeting EGFR and PI3K

Cancer prevention research (Philadelphia, Pa.), 2012-09, Vol.5 (9), p.1103-1114

2012

Volltextzugriff (PDF)

Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator

EBioMedicine, 2019-11, Vol.49, p.72-81

2019

Volltextzugriff (PDF)

Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention

Molecular carcinogenesis, 2015-06, Vol.54 (S1), p.E129-E137

2015

Volltextzugriff (PDF)

Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1

PloS one, 2013-09, Vol.8 (9), p.e74188

2013

Volltextzugriff (PDF)

Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations

Frontiers in cell and developmental biology, 2023-04, Vol.11, p.1170444-1170444

2023

Volltextzugriff (PDF)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ

PloS one, 2015-10, Vol.10 (10), p.e0141849

2015

Volltextzugriff (PDF)

Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention

NPJ precision oncology, 2023-10, Vol.7 (1), p.108-108, Article 108

2023

Volltextzugriff (PDF)

Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine‐induced urinary bladder cancers

International journal of cancer, 2008-11, Vol.123 (10), p.2254-2259

2008

Volltextzugriff (PDF)

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

Communications biology, 2021-07, Vol.4 (1), p.906-11, Article 906

2021

Volltextzugriff (PDF)

Discovery of Novel Checkpoint Kinase 1 Inhibitors by Virtual Screening Based on Multiple Crystal Structures

Journal of chemical information and modeling, 2011-11, Vol.51 (11), p.2904-2914

2011

Volltextzugriff (PDF)

Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity

Cancer prevention research (Philadelphia, Pa.), 2012-05, Vol.5 (5), p.717-725

2012

Volltextzugriff (PDF)

Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma

Cancers, 2019-04, Vol.11 (4), p.477

2019

Volltextzugriff (PDF)

Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models

Cancer prevention research (Philadelphia, Pa.), 2015-03, Vol.8 (3), p.231-239

2015

Volltextzugriff (PDF)

Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors

Metabolites, 2019-07, Vol.9 (7), p.149

2019

Volltextzugriff (PDF)

Effect of Dietary Polyphenon E and EGCG on Lung Tumorigenesis in A/J Mice

Pharmaceutical research, 2010-06, Vol.27 (6), p.1066-1071

2010

Volltextzugriff (PDF)

Short-term Modulation of Cell Proliferation and Apoptosis and Preventive/Therapeutic Efficacy of Various Agents in a Mammary Cancer Model

Clinical cancer research, 2007-09, Vol.13 (18), p.5488-5496

2007

Volltextzugriff (PDF)

Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2

PloS one, 2013-10, Vol.8 (10), p.e76452

2013

Volltextzugriff (PDF)

Differential Gene Expression in Human Lung Adenocarcinomas and Squamous Cell Carcinomas

Clinical cancer research, 2002-04, Vol.8 (4), p.1127-1138

2002

Volltextzugriff (PDF)

Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo

Molecular cancer therapeutics, 2013-06, Vol.12 (6), p.950-958

2013

Volltextzugriff (PDF)

Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis

Clinical cancer research, 2004-10, Vol.10 (19), p.6703-6709

2004

Volltextzugriff (PDF)

1 – 25 von 454

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(427)
Mit Volltextzugriff
(436)

Publikationsform

Sprache

Englisch
(454)
Japanisch
(60)

Erscheinungsjahr

n.n

Thema

Science & Technology
(292)
Life Sciences & Biomedicine
(282)
Animals
(270)
Oncology
(199)
Biological And Medical Sciences
(159)
Female
(143)
Medical Sciences
(143)
Mice
(137)
Rats
(135)
Tumors
(111)
Male
(100)
Humans
(79)
Chemoprevention
(63)
Rats, Inbred F344
(58)
Carcinogenesis, Carcinogens And Anticarcinogens
(57)
Anticarcinogenic Agents - Pharmacology
(52)
Rats, Sprague-Dawley
(52)
Biochemistry & Molecular Biology
(46)
Disease Models, Animal
(46)
Chemical Agents
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer

Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention

Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity

Prediction of molecular targets of cancer preventing flavonoid compounds using computational methods

Taxifolin suppresses UV-induced skin carcinogenesis by targeting EGFR and PI3K

Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator

Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention

Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1

Major hurdles to the use of tyrosine kinase inhibitors in clinical prevention/interception studies: Do preclinical studies with EGFR inhibitors suggest approaches to overcome some of the limitations

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ

Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention

Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine‐induced urinary bladder cancers

Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

Discovery of Novel Checkpoint Kinase 1 Inhibitors by Virtual Screening Based on Multiple Crystal Structures

Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity

Exosomal miRNAs as Novel Pharmacodynamic Biomarkers for Cancer Chemopreventive Agent Early Stage Treatments in Chemically Induced Mouse Model of Lung Squamous Cell Carcinoma

Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models

Pharmacometabolomic Pathway Response of Effective Anticancer Agents on Different Diets in Rats with Induced Mammary Tumors

Effect of Dietary Polyphenon E and EGCG on Lung Tumorigenesis in A/J Mice

Short-term Modulation of Cell Proliferation and Apoptosis and Preventive/Therapeutic Efficacy of Various Agents in a Mammary Cancer Model

Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2

Differential Gene Expression in Human Lung Adenocarcinomas and Squamous Cell Carcinomas

Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo

Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis

Suchergebnisse filtern